No Data
No Data
No Data
No Data
No Data
Pharmesis' Attributable Loss for 2023 Widens
Pharmesis (SGX:BFK) booked an attributable loss to equity holders of 5.0 million yuan in the year ended Dec. 31, 2023, compared with 3.6 million yuan in the year-ago period, according to an annual rep
MT NewswiresApr 14 23:07 ET
Pharmesis Launches New Product Line
Pharmesis' (SGX:BFK) wholly owned subsidiary, Chengdu Kinna launched a new product line called Infinity Wolfberry Products, according to a filing with the Singapore Exchange on Monday. The product lin
MT NewswiresMar 26 01:47 ET
Express News | Pharmesis International Flags Losses for H1
Moomoo 24/7Aug 9, 2023 06:41 ET
Pharmesis International Issues 4.6 Million Shares to Two Subscribers
11:49 PM EDT, 04/05/2023 (MT Newswires) -- Pharmesis International (SGX:BFK) issued and allotted 4.6 million shares at SG$0.10 each to two subscribers, Yu Yi-Wen and Zheng Haoyuan, to raise SG$407,000
MT NewswiresApr 5, 2023 23:51 ET
Pharmesis International Gets Regulatory Nod to List 4.6 Million Shares
04:04 AM EDT, 03/29/2023 (MT Newswires) -- Pharmesis International (SGX:BFK) obtained approval in-principle from the Singapore Exchange for the listing and quotation of 4.6 million shares to be issued
MT NewswiresMar 29, 2023 04:06 ET
Pharmesis International to Issue 4.6 Million Shares to Two Subscribers
08:11 AM EDT, 03/21/2023 (MT Newswires) -- Pharmesis International (SGX:BFK) will issue a total of 4.6 million shares at SG$0.10 each to two subscribers to raise net proceeds of SG$407,000. The compan
MT NewswiresMar 21, 2023 08:12 ET
No Data
No Data